MARKET

TCMD

TCMD

Tactile Systems
NASDAQ
14.27
-0.77
-5.12%
After Hours: 14.00 -0.27 -1.89% 17:03 04/25 EDT
OPEN
14.90
PREV CLOSE
15.04
HIGH
14.90
LOW
13.90
VOLUME
273.25K
TURNOVER
0
52 WEEK HIGH
26.11
52 WEEK LOW
9.70
MARKET CAP
339.05M
P/E (TTM)
11.60
1D
5D
1M
3M
1Y
5Y
Tactile Systems Technology and ESCO Technologies have been highlighted as Zacks Bull and Bear of the Day
NASDAQ · 1d ago
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Tactile Systems Technology (TCMD) and Danaher (DHR)
TipRanks · 1d ago
Bull Of The Day: Tactile Systems Technology (TCMD)
NASDAQ · 1d ago
Tactile Systems Announces CEO Transition and Compensation Details
TipRanks · 2d ago
Tactile Systems Technology Names Sheri Dodd CEO, Reuvers to Retire
Tactile Systems Technology named Sheri Dodd as its next chief executive. She succeeds Dan Reuvers, who is retiring effective July 1. Dodd has nearly three decades of experience in the pharmaceutical, medical device and digital health industries. She rose to president of Medtronic Canada and worked at Johnson & Johnson.
Dow Jones · 2d ago
Tactile Systems Technology names Sheri Dodd as CEO
Tactile Systems Technology names Sheri Dodd as CEO effective July 1. Dodd succeeds Dan Reuvers, who will retire as the company's CEO effective June 30. The company expects Q1 revenue of $61.2M. TCMD stock is down 2.7% in the last week.
Seeking Alpha · 2d ago
*Tactile Systems Tech Sees 1Q Rev $61M >TCMD
Dow Jones · 2d ago
TACTILE SYSTEMS TECHNOLOGY INC: TOTAL REVENUE FOR Q1 OF 2024 IS EXPECTED TO BE APPROXIMATELY $61 MLN
Reuters · 2d ago
More
About TCMD
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.

Webull offers Tactile Systems Technology Inc stock information, including NASDAQ: TCMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TCMD stock methods without spending real money on the virtual paper trading platform.